跳至主要内容
临床试验/NCT02221362
NCT02221362终止不适用

A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease

BioMarin Pharmaceutical15 个研究点 分布在 9 个国家目标入组 30 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
30
试验地点
15
主要终点
To evaluate the degree of change in respiratory and endurance endpoints over time in patients with Pompe disease

研究概览

简要总结

Study 701-901, a multicenter, multinational, longitudinal, non-interventional observational study in subjects, at least 18 years old, diagnosed with late-onset Pompe disease prospectively collects data to understand clinical progression in terms of respiratory function, symptomology, genotype, biochemistry, endurance and selected subject-reported measures for 24 weeks followed by a 240 week additional observation period for up to 100 subjects.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to provide written informed consent after the nature of the study has been explained and prior to any study-related procedure
  • Diagnosed with late-onset Pompe disease based on current or previous genomic testing and/or endogenous GAA activity
  • At least 18 years of age at study entry
  • Willing and able to comply with all study procedures

排除标准

  • Requires non-invasive ventilatory support while awake and in the upright position
  • Concurrent disease, medical condition, or extenuating circumstance that, in the opinion of the investigator, might compromise study completion or data collection
  • Unable to perform baseline efficacy assessments

结局指标

主要结局

To evaluate the degree of change in respiratory and endurance endpoints over time in patients with Pompe disease

时间窗: 264 Weeks

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验